Piton Therapeutics Inc

Piton Therapeutics Inc. is a small company based in Watertown Town, Massachusetts, with 10 employees. Piton Therapeutics specializes in developing small molecule drugs that target pathogenic pathways in the gut lumen. Their focus is on developing life-changing therapeutics for chronic conditions with limited treatment options, particularly in the areas of Inflammatory Bowel Disease/Ulcerative Colitis, Autism Spectrum Disorder, and Parkinson's Disease. The company utilizes a proprietary platform that leverages AI to identify promising drug candidates. Piton's approach to Ulcerative Colitis targets a specific cause of the disease in a significant portion of patients, potentially revolutionizing treatment. Their research suggests their therapeutic strategy may also be applicable to type 2 diabetes and weight management. For Autism Spectrum Disorder, Piton has validated their approach in in-vivo experiments and is exploring several drug candidates that could be the first approved medication to treat core ASD symptoms. Their research on Parkinson's Disease has led to a novel therapeutic intervention target with potential applications across various chronic diseases. For more information about Piton Therapeutics Inc., visit their website at pitontx.com.